GLP-1 seems to inhibit the production of glucagon, which should directly reduce the amount of glucose in blood, which is a desired effect for treating obesity. On the other hand, it seems to stimulate insulin production, which also reduces glucose, but extra insulin may cause insulin resistance, which can contribute to type II diabetes. Insulin resistance can take years to develop, so maybe you should test for that if you use GLP-1 long term.
